Richard Francis | President & CEO |
Eli Kalif | CFO |
Dr. Eric Hughes | CMO, Head of R&D |
Sven Dethlefs | Head, North America Commercial |
Ran Meir | IR |
Jason Gerberry | Bank of America |
Umer Raffat | Evercore ISI |
Mikaela Franceschina | Barclays |
Ash Verma | UBS |
Thibault Boutherin | Morgan Stanley |
David Amsellem | Piper Sandler |
Chris Schott | J.P. Morgan |
Hello, and welcome to the Q2 2023 Teva Pharmaceutical Industries Limited earnings conference call. My name is Alex. I'll be coordinating the call today. [Operator instructions].
I'll now hand over to your host, Ran Meir, head of Investor Relations.